According to the latest report by IMARC Group, titled “India Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The India generic injectables market reached a value of US$ 2.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2027, exhibiting a CAGR of 12.8% during 2022-2027.
Generic injectables refer to pharmaceutical drugs that consist of active ingredients, effectiveness, intended use, strength, quality, and dosage that are similar to their branded counterparts. They can be divided into various kinds, including monoclonal antibodies, insulin, cytokines, peptide hormones, blood factors, vaccines, etc. Generic injectables are utilized to treat several life-threatening and chronic diseases, such as cancer, diabetes, cardiovascular ailments, rheumatoid arthritis, and respiratory infections. Compared to innovator drugs, they aid in ensuring maximized patient compliance, limited price erosion, reduced frequency of drug delivery, higher profitability for manufacturers, etc. As a result, generic injectables find widespread applications across hospitals, clinics, medical centers, pharmacies, etc.
Request Free Sample Report: https://www.imarcgroup.com/india-generic-injectables-market/requestsample
India Generic Injectables Market Trends and Drivers:
The escalating prevalence of chronic diseases, owing to the rising pollution levels and the unhealthy lifestyles of individuals, is primarily driving the India generic injectables market. Apart from this, the development of advanced drug variants for effective administration and faster recovery of patients is further augmenting the market growth. Moreover, the improving healthcare facilities are also catalyzing the market across India. In addition to this, the expanding life science sector and the inflating technological advancements in drug delivery systems, including the introduction of self-injection devices, are acting as significant growth-inducing factors. Furthermore, the increasing expiry of branded medicines and patent items is expected to bolster the India generic injectables market in the coming years.
India Generic Injectables Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
The report has segmented the market on the basis on region, therapeutic area, container and distribution channel.
Breakup by Therapeutic Area:
- Oncology
- Anaesthesia
- Anti-infectives
- Parenteral Nutrition
- Cardiovascular
Breakup by Container:
- Vials
- Ampoules
- Premix
- Prefilled Syringes
Breakup by Distribution Channel:
- Hospitals
- Retail Pharmacy
Breakup by Region:
- North India
- West and Central India
- South India
- East India
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/india-generic-injectables-market
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group